These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 9253238
21. Effect of different concentrations of diphtheria toxoid & aluminum phosphate on potency of diphtheria component in DPT vaccines. Gupta P, Saxena SN, Kumar A, Gupta P. Indian J Med Res; 1990 May; 91():171-3. PubMed ID: 2118880 [Abstract] [Full Text] [Related]
22. International collaborative studies on potency assays of diphtheria and tetanus toxoids. Van Ramshorst JD, Sundaresan TK, Outschoorn AS. Bull World Health Organ; 1972 May; 46(2):263-76. PubMed ID: 4537488 [Abstract] [Full Text] [Related]
23. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Halperin SA, King J, Law B, Mills E, Willems P. Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624 [Abstract] [Full Text] [Related]
24. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria. Vrancheva S, Vulchev V, Bachev S. Prog Immunobiol Stand; 1970 May; 4():548-52. PubMed ID: 5482199 [No Abstract] [Full Text] [Related]
25. Contraindications to vaccination in the Russian Federation. Tatochenko V, Mitjushin IL. J Infect Dis; 2000 Feb; 181 Suppl 1():S228-31. PubMed ID: 10657219 [Abstract] [Full Text] [Related]
26. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine. Iwaki M, Komiya T, Fukuda T, Arakawa Y, Takahashi M. Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650 [No Abstract] [Full Text] [Related]
27. [Seroepidemiological survey on diphtheria and tetanus immunization coverage in adolescents in Calabria]. Pavia M, Indovino A, Talarico F, Angelillo IF. Ann Ig; 1996 Aug; 8(4):411-8. PubMed ID: 9235011 [No Abstract] [Full Text] [Related]
28. Passive haemagglutination tests using purified antigens covalently coupled to turkey erythrocytes. Relyveld EH, Huet M, Lery L. Dev Biol Stand; 1996 Aug; 86():225-41. PubMed ID: 8785953 [Abstract] [Full Text] [Related]
29. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered. Daum RS, Zenko CE, Given GZ, Ballanco GA, Parikh H, Germino K. J Infect Dis; 2001 Nov 15; 184(10):1293-9. PubMed ID: 11679918 [Abstract] [Full Text] [Related]
30. Vaccination against diphtheria and tetanus. Assays, antigens, adjuvants and application. Aggerbeck H. APMIS Suppl; 1998 Nov 15; 81():1-40. PubMed ID: 9810281 [No Abstract] [Full Text] [Related]
31. [Comparative immunologic effectiveness of variants of the DTP vaccine]. Baeva EA, Selezneva TS, Rezepov FF, Chebotareva SV, El'nitskaia EA. Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct 15; (10):50-2. PubMed ID: 2879402 [Abstract] [Full Text] [Related]
32. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines. Csizér Z, Zsidai J. Ann Immunol Hung; 1979 Oct 15; 19():53-74. PubMed ID: 552225 [Abstract] [Full Text] [Related]
33. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay. Aggerbeck H, Heron I. Dev Biol Stand; 1996 Oct 15; 86():297-301. PubMed ID: 8785958 [Abstract] [Full Text] [Related]
34. Liposomes as immunological adjuvants for tetanus vaccine. Popescu C, Durbaca S, Ivanov D. Roum Arch Microbiol Immunol; 1998 Oct 15; 57(3-4):263-9. PubMed ID: 11845438 [Abstract] [Full Text] [Related]
35. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR. Pediatrics; 2006 Apr 15; 117(4):1084-93. PubMed ID: 16585302 [Abstract] [Full Text] [Related]
36. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines. Knight PA, Roberts PA. Dev Biol Stand; 1986 Apr 15; 65():245-53. PubMed ID: 3493931 [Abstract] [Full Text] [Related]
37. Immunization status of school children. Goud BN, Rao KV, Rao MN, Reddi YR. Indian Pediatr; 1980 Aug 15; 17(8):667-73. PubMed ID: 6785226 [No Abstract] [Full Text] [Related]
38. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine. Auerbach BS, Lake AM, Wilson ME, Willingham FF, Shematek J, Moulton L, Deforest A, Halsey NA. Biologicals; 1998 Jun 15; 26(2):145-53. PubMed ID: 9811522 [Abstract] [Full Text] [Related]
39. [Value of national standards in the control of standardization of diphtheria and tetanus anatoxins. Conditions of measurement in international units and immunogenic value of tetanus anatoxin for guinea pigs and mice]. Demian L, Lazăr M. Arch Roum Pathol Exp Microbiol; 1969 Jun 15; 28(2):297-302. PubMed ID: 5400034 [No Abstract] [Full Text] [Related]
40. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines. Huebner RE, Nicol M, Mothupi R, Käyhty H, Mbelle N, Khomo E, Klugman KP. Vaccine; 2004 Dec 21; 23(6):802-6. PubMed ID: 15542205 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]